Sara J. Runge, MD
General Surgeon
Lung Cancer Ovarian Cancer Peritoneal Mesothelioma Pleural Effusions Testicular Mesothelioma
Catheter Placement Cytoreduction with HIPEC Extrapleural Pneumonectomy (EPP) Laparoscopy Segmentectomy Shunt Placement
UCSF Medical Center St. John's Pleasant Valley Hospital St. John's Regional Medical Center
Dr. Sara Runge is a surgeon based in Ventura, California. Her primary specialties are general surgery and vascular surgery. She has graduated from the University of Minnesota Medical School and continued her education path with a residency in general surgery at the University of California. She completed her formative course with a fellowship in vascular surgery at the University of Florida. Dr. Runge is a board-certified surgeon both in general surgery and vascular and vein therapy. She is also a registered physician in vascular interpretation and a member of various medical organizations including the American College of Surgeons. She has also been involved in the research field, publishing two studies focused on the following subjects: mediastinal lymph node activity in gynecologic malignancies and the infrapopliteal peripheral arterial occlusive disease. Dr. Sara Runge currently collaborates with the UCSF Medical Center, St. John's Regional Medical Center and St. John's Pleasant Valley Hospital.
University of Minnesota
Medical School
UCSF
Residency
University of Florida
Fellowship
American Board of Surgery
St. John's Pleasant Valley Hospital
Languages: English/Spanish
(805) 389-5800
2309 Antonio Ave
Read MoreSt. John's Regional Medical Center
Languages: English/Spanish
(805) 988-2500
1600 N Rose Ave
Read MoreUCSF Medical Center
Languages: English/Spanish
(415) 353-1037
505 Parnassus Ave
San Francisco, California 94143
Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease.
Vartanian, S. M.,Johnston, P. C.,Walker, J. P.,Runge, S. J.,Eichler, C. M.,Reilly, L. M.,Hiramoto, J. S.,Conte, M. S.; J. Vasc. Surg.. 2013 Jul 30.
See more >>D-series resolvins attenuate vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury.
Miyahara, T.,Runge, S.,Chatterjee, A.,Chen, M.,Mottola, G.,Fitzgerald, J. M.,Serhan, C. N.,Conte, M. S.; FASEB J. 2013 Jun.
See more >>Management of Infrapopliteal Peripheral Arterial Occlusive Disease.
Gasper, W.J., Runge, S.J., Owens, C.D.; Curr Treat Options Cardiovasc Med. 2012 Apr.
See more >>American College of Surgeons